Unlocking a Death Sentence for Cancer: The Potential Game-Changer in CAR T-Cell Therapy
Researchers at UC Davis Comprehensive Cancer Center and Indiana University School of Medicine have made a significant breakthrough in cancer treatment. They discovered that CD95, or Fas receptors, can trigger a natural process of programmed cell death. This opens the possibility to target a specific part of the Fas receptor that initiates cell death, potentially …
Unlocking a Death Sentence for Cancer: The Potential Game-Changer in CAR T-Cell Therapy Read More »